Opening case: An unexpected outcome
Once upon a time there was a patient with cardiogenic shock due to a myocardial infarction. Although normotensive, he wasn't perfusing his kidneys. His echocardiogram showed all of the expected features of cardiogenic shock, including a severely reduced ejection fraction and dilated inferior vena cava. He had a Swan-Ganz catheter which showed very low cardiac output, high filling pressures, and high systemic vascular resistance.
The patient's Swan numbers and echocardiogram suggested that he should respond well to milrinone, a drug that ought to increase his ejection fraction while simultaneously reducing his afterload. This would shift his physiology closer to normal.
However, a while after starting the milrinone the patient's blood pressure plummeted to a systolic blood pressure in the 60s. A high-dose epinephrine infusion was needed to raise his blood pressure until the milrinone wore off. What went wrong?
With milrinone, his systemic vascular resistance decreased but his cardiac output remained unchanged, causing his blood pressure to fall. The patient's cardiac output was not milrinone responsive. His ventricle was already working at maximal capacity, in the setting of a massive infarction. The echo and swan data provided the illusion that we understood his hemodynamics, but failed to predict how he would respond to milrinone. They caused us to be wrong with confidence, the most dangerous combination in medicine (1).
Use of Swan-Ganz catheterization in heart failure is increasing, despite evidence-based recommendations to the contrary (Pandey 2016). This trend may reflect increased utilization of advanced therapies in heart failure (e.g., LVADs). With a resurgence of the Swan, a resident recently asked me: why don't we use the Swan to guide sepsis resuscitation? Answering this question forced me to recognize that many problems with the Swan continue to haunt us today when using our new darling, bedside echocardiography.
First reason we fail: The flaw of averages
Let's consider a simple question: Does dobutamine increase cardiac index in septic shock? There have been about a dozen prospective RCTs investigating this, with a meta-analysis showing that dobutamine increases cardiac index (Nadeem 2015). This is also what every textbook and review article says. Seems simple, right?
Closer reading of the hemodynamic literature yields a more complex answer. For example, Enrico 2012 published data from individual patients with septic shock treated with dobutamine (below). In some patients dobutamine increased the cardiac output, but in many patients it had little effect:
Unfortunately, most research on hemodynamics focuses on average patient data, ignoring this heterogeneity. Average data can be misleading. For example, the average data from this same study by Enrico 2012 shows that dobutamine increases cardiac index (red box below). Without seeing the individual patient data, there is a natural tendency to assume that dobutamine increases the cardiac output in all patients.
Many other studies have also found striking heterogeneity in the responses of septic patients to dobutamine. For example, Kumar 2007 found that patients who survived were more likely to experience an increased stroke volume in response to dobutamine (adjacent figure).
The flaw of averages refers to inappropriate assumptions that the average applies to all cases. This gets us into trouble clinically, because it deludes us into believing that we can accurately predict the effect of a drug. For example, in the opening case, we were sure that milrinone would increase the patient's cardiac output because this is the average response to milrinone.
Second reason we fail: The Swan's Curse
The swan attempts to give us a snapshot of the patient's hemodynamics. Although this contains a lot of information, it isn't the information that we need. The Swan provides only static hemodynamic measurements, which don't actually help us determine how to treat the patient. The following two examples illustrate this problem.
Example #1: The Swan doesn't help guide fluid management
Historically, the first variable of interest after a Swan was placed was the pulmonary capillary wedge pressure. Ideally, the wedge pressure should reflect the preload on the left ventricle (2). Thus, the wedge pressure was used as a tool to guide fluid resuscitation.
Unfortunately, this doesn't work. Technical problems aside, filling pressures (e.g. wedge pressure, central venous pressure) cannot guide fluid resuscitation because they are static variables which don't measure fluid responsiveness.
Whether the patient responds to fluid depends on interactions between the preload and cardiac function. For example, a patient with severe heart failure might reach a maximal cardiac output rapidly, even with a low pulmonary capillary wedge pressure (point B). Alternatively, a patient with good cardiac function might be fluid-responsive at exactly the same wedge pressure (point A). Thus, the wedge pressure cannot predict fluid responsiveness.
Example #2: The Swan doesn't help guide inotropic therapy
The other proposed use of a Swan in septic shock is to identify patients with low cardiac output who would benefit from inotropic therapy (e.g. dobutamine)(3). Unfortunately, this doesn't work either.
Vallet 1993 evaluated the response of 50 patients with septic shock to an infusion of 10 mcg/min/kg dobutamine. Only about half of the patients responded well, with improved oxygen consumption and cardiac output (5). The Swan hemodynamic profiles of responders and nonresponders were identical (table). Thus, a Swan cannot predict which patients will benefit from dobutamine. This finding was confirmed by Rhodes 1999.
Inability of cardiac output to predict dobutamine responsiveness may be due to many factors. However, a simple illustration of how this could occur is as follows. Lets again consider two septic patients, one of whom has a cardiomyopathy. To compensate for the cardiomyopathy, Patient #2's endogenous sympathetic activity is increased (so Patient #2 starts out at point B, prior to administering any dobutamine). These two patients have the same baseline cardiac output, but only Patient #1 will respond well to exogenous dobutamine.
Theoretically, by frequently repeating Swan numbers, we could get a better sense of the responsiveness of the hemodynamic system to various interventions. Unfortunately, in usual clinical practice the Swan isn't precise enough to reliably detect changes in serial hemodynamics (Marik 2013). Meanwhilele, when scrutinizing differences between serial sets of Swan data, it's easy to be misled by random variations.
The Swan's curse
The Swan's curse is that even if we know intellectually that static variables don't predict responsiveness, it is exceedingly difficult to ignore them. We see a wedge pressure of 5 mm in a patient with sepsis, and even though we know that this doesn't predict fluid responsiveness, we still want to give fluids. Although wrong, this response is intuitive and nearly irresistible. This explains why it is probably wisest not to measure a wedge pressure (or a CVP) in the first place.
Bedside echocardiography: The curse continues
Currently, the Swan has largely been replaced by echocardiography for hemodynamic evaluation. The diagnostic capacity of echocardiography is vastly superior to the swan. For example, echocardiography can immediately and definitively identify a range of hemodynamic diagnoses (e.g. RV failure, tamponade, hypovolemic shock, valvular regurgitation).
Echocardiography is also being used to guide resuscitation, as a hemodynamic monitor. Although this shows considerable promise, it also suffers from many of the same pitfalls that the Swan did. Most findings on echocardiography are, once again, static variables.
IVC diameter is the new CVP
Perhaps the most notable example is the IVC diameter. Some clinicians who scoff at using CVP to guide sepsis resuscitation will nonetheless infuse crystalloid until the IVC is distended. However, IVC diameter is largely a reflection of CVP:
A common error is assuming that a small IVC indicates volume depletion. IVC size and CVP are not measurements of volume status, but rather they are determined by the interaction of cardiac function and volume status (e.g. a small IVC can be caused by vasodilation). Thus, assuming that a patient with a small IVC needs fluid is wrong for two reasons:
- Small IVC doesn't necessarily mean the patient is volume depleted
- Like CVP, IVC size doesn't predict volume responsiveness.
Unfortunately, an underfilled IVC is visually striking, it's sitting right there, and it looks empty. Regardless of our intellectual understanding of hemodynamics, we feel compelled to fill the IVC. The curse continues (4).
Ejection fraction is the new cardiac index
Ejection fraction may have similar problems compared to the cardiac index. For example, remember the patient above with cardiogenic shock who was nearly killed by milrinone? That patient had a severely reduced ejection fraction, which could suggest a benefit from milrinone. Unfortunately, baseline echocardiography fails to reveal the responsiveness of the ejection fraction to milrinone. Thus, newer technology may generate the same errors that were previously encountered with the Swan (5).
Responsiveness: The cure for the Swan's curse
The cure for static variables is understanding dynamic variables. Considerable progress has been made in the past few years in understanding fluid responsiveness (explored in an epic podcast by Scott Weingart).
In addition to fluid responsiveness, we may need to pay more attention to vasopressor responsiveness and inotrope responsiveness. The response of individual patients is more heterogeneous and unpredictable than suggested by textbooks. Therefore, rather than assuming that the patient will respond in an average way, we may need to carefully administer a drug and monitor the individual patient's response.
To be continued… this is part three of a four-part series on hemodynamics.
- Although echocardiography is safer than Swan-Ganz catheterization, it is susceptible to some of the same cognitive errors.
- Our understanding of how medications affect hemodynamics is based on the average response of groups of patients. Unfortunately, it may be incorrect to assume that an individual patient will respond similarly to the average (“Flaw of averages”).
- Most variables obtained from either Swan-Ganz catheterization or bedside echocardiography are static variables. These describe the current state of the patient's hemodynamics, but don't predict how the patient will respond to various interventions. Unfortunately, there is a natural tendency to base therapeutic decisions on static variables which are easily observable (“Swan's Curse”).
- Best article ever written about hemodynamic monitoring: Alice in Intensiveland.
- Fluid responsiveness (EMCrit)
- Empty IVC + hyperkinetic heart doesn't equal volume depletion (PulmCrit)
- IVC for decisions on fluid status (EMCrit)
- Current series on hemodynamics
- One key factor that made this dangerous is that milrinone is renally cleared, so that it may accumulate over time. Thus, it may initially seem that the patient is doing fine, but over time the drug level may build up and cause problems.
- There are about a dozen potentially confounding variables, which can cause the wedge pressure to be inaccurate. However, for now let's ignore these and suppose that the wedge pressure can actually measure the preload on the LV.
- Epinephrine is my inotrope of choice in sepsis for reasons which have been explored previously. Dobutamine is used here because there is more data about its effect on hemodynamics. More on epinephrine next week.
- Please note that this discussion pertains to IVC size, not IVC variability. IVC variability is an entirely different topic which has been explored previously here.
- This study defined “responders” vs. “non-responders” based on whether there was an increase in oxygen consumption (VO2). However, VO2 was closely correlated with DO2 and cardiac output, such that patients who were “dobutamine responders” were predominantly patients who experienced significant increases in cardiac output.
Image credit: Black Swan from Wikipedia.
Latest posts by Josh Farkas (see all)
- PulmCrit:Validation of test-dose strategy for beta-lactam allergies - May 20, 2019
- IBCC chapter & cast: Rhabdomyolysis - May 16, 2019
- IBCC chapter & cast:hypophosphatemia and hyperphosphatemia - May 9, 2019